A systematic review of the health economic consequences of quadrivalent influenza vaccination - Département Méthodes quantitatives en santé publique Accéder directement au contenu
Article Dans Une Revue Expert Review of Pharmacoeconomics and Outcomes Research Année : 2017

A systematic review of the health economic consequences of quadrivalent influenza vaccination

Résumé

Quadrivalent influenza vaccines (QIVs) contain antigens derived from an additional influenza type B virus as compared with currently used trivalent influenza vaccines (TIVs). This should overcome a potential reduced vaccine protection due to mismatches between TIV and circulating B viruses. In this study, we systematically reviewed the available literature on health economic evaluations of switching from TIV to QIV. Areas covered: The databases of Medline and Embase were searched systematically to identify health economic evaluations of QIV versus TIV published before September 2016.A total of sixteen studies were included, thirteen cost-effectiveness analyses and three cost-comparisons. Expert commentary: Published evidence on the cost-effectiveness of QIV suggests that switching from TIV to QIV would be a valuable intervention from both the public health and economic viewpoint. However, more research seems mandatory. Our main recommendations for future research include: 1) more extensive use of dynamic models in order to estimate the full impact of QIV on influenza transmission including indirect effects, 2) improved availability of data on disease outcomes and costs related to influenza type B viruses, and 3) more research on immunogenicity of natural influenza infection and vaccination, with emphasis on cross-reactivity between different influenza B viruses and duration of protection.
Fichier principal
Vignette du fichier
document (6).pdf (2.08 Mo) Télécharger le fichier
Origine : Publication financée par une institution
Loading...

Dates et versions

hal-01548937 , version 1 (28-06-2017)

Licence

Paternité - Pas d'utilisation commerciale - Pas de modification

Identifiants

Citer

P.T. de Boer, B.M. van Maanen, Oliver Damm, Bernhard Ultsch, Franklin C.K. Dolk, et al.. A systematic review of the health economic consequences of quadrivalent influenza vaccination. Expert Review of Pharmacoeconomics and Outcomes Research, 2017, 17 (3), pp.249-265. ⟨10.1080/14737167.2017.1343145⟩. ⟨hal-01548937⟩
300 Consultations
147 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More